# Allogenic Cord Blood Transfusion in Patients With Autism

> **NCT03786744** · PHASE1,PHASE2 · COMPLETED · sponsor: **State-Financed Health Facility "Samara Regional Medical Center Dinasty"** · enrollment: 20 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Autism

## Interventions

- **BIOLOGICAL:** ASD CB-MNC injection.
- **OTHER:** Standard therapy.

## Key facts

- **NCT ID:** NCT03786744
- **Lead sponsor:** State-Financed Health Facility "Samara Regional Medical Center Dinasty"
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-12
- **Primary completion:** 2019-10-12
- **Final completion:** 2019-12-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03786744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03786744, "Allogenic Cord Blood Transfusion in Patients With Autism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03786744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*